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Genetic mechanisms of methicillin resistance are still relevant in staphylococci. The aims of this
study are to assess the possible exchanges of staphylococcal cassette chromosome mec
(SCCmec) among isolates of methicillin-resistant staphylococci (MRS) and to check for known
or new mutations in mecA DNA. A total of 35 MRS non-repetitive isolates were recovered,
including 20 Staphylococcus haemolyticus, 7 Staphylococcus aureus, 4 Staphylococcus sciuri,
2 Staphylococcus saprophyticus and 1 isolate each of Staphylococcus xylosus and
Staphylococcus lentus. Only 16 of the 35 strains were assigned to known SCCmec types: 7
SCCmec VII, 6 SCCmec IV and 3 SCCmec III, with possible horizontal transfer of the SCCmec
VII from methicillin-resistant S. haemolyticus to methicillin-susceptible S. aureus. mecA gene
sequencing in ten selected isolates allowed description of nine punctual mutations, seven of
which were reported for the first time. The most frequent mutation was G246E, identified in
isolates of methicillin-resistant S. aureus, S. sciuri, S. saprophyticus and S. lentus. These results
emphasized the high degree of genetic diversity of SCCmec element in MRS and describe new
missense mutations in mecA, which might be important in understanding the evolution of
methicillin and new b-lactam resistance.
INTRODUCTION
Coagulase-negative staphylococci (CNS) are normal inhabi-
tants of human skin and mucous membranes, but their role
as pathogens and their increasing impact have been recently
recognized. CNS now represent one of the major nosocomial
pathogens, with Staphylococcus epidermidis and Staphylococ-
cus haemolyticus being the most significant species (Becker
et al., 2014a). Since 1970, CNS have been recognized as aetio-
logic agents of a wide range of infections, including bacterae-
mia, central nervous system shunt infection, endocarditis,
urinary tract infection, surgical site infections, endophthalmi-
tis, foreign body infection and many other infections. Most
frequently, patients with CNS infections are immunocom-
promised, with indwelling or implanted foreign bodies
(Piette & Verschraegen, 2009; Becker et al., 2014a).
A further alarming concern is about the spread of drug resis-
tance within different species of staphylococci. Within resis-
tance mechanism to b-lactam antibiotics, the mecA gene
plays the keystone role, and confirming its presence has been
established as a ‘diagnostic dogma’ to categorize an isolate as
methicillin-resistant staphylococci (MRS). However, more
recent studies have demonstrated that this approach does not
take into account that phenotypic methicillin (and other b-
lactam) resistance in Staphylococcaceae is conferred not only
by mecA but also by the homologous genes mecB and mecC
(Hiramatsu et al., 2013; Becker et al., 2014b). Even if the ori-
gin ofmecA gene in methicillin-resistant Staphylococcus aureus
Abbreviations: CNS, coagulase-negative staphylococci; IWG-SCC, Inter-
national Working Group on the Classification of Staphylococcal Cas-
sette Chromosome Elements; MGE, mobile genetic element; M-PCR,
multiplex PCR; MR, methicillin-resistant; MRS, methicillin-resistant
staphylococci; MRSA, methicillin-resistant Staphylococcus aureus;
SCCmec, staphylococcal cassette chromosome mec.
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(MRSA) remains unknown, several studies have demon-
strated its high similarity degrees with mecA of Staphylococcus
sciuri and Staphylococcus fleurettii, suggesting that these might
be sources of mecA precursor (Wu et al., 1996; Tsubakishita
et al., 2010).
In MRS,mecA gene confers resistance to almost all b-lactam
molecules by the synthesis of a new penicillin-binding pro-
tein, ‘PBP2a’. However, ceftaroline and ceftobiprole, new
cephalosporin molecules recently introduced and approved
for the treatment of community-acquired pneumonia and
complicated skin and soft tissue infections, are active against
MRS. Ceftaroline causes an allosteric change of PBP2a so
that a second molecule can bind to the newly exposed active
site (Fishovitz et al., 2014) and ceftobiprole can access the
active site of PBP2a through its residue R2 (Chan et al.,
2015). In spite of these developments, mecA gene is still at
the centre of interest for the scientific community because of
recent reports on ceftaroline- and ceftobiprole-resistant
MRSA isolates, mainly due to mutations in mecA (Chan
et al., 2015; Schaumburg et al., 2016). This resistance is not
due to a selective pressure following the introduction of
these molecules but due to specific mutations in some mecA
allotypes (Schaumburg et al., 2016).
mecA is carried on a mobile genetic element (MGE), known
as the ‘staphylococcal cassette chromosome mec’ or
SCCmec. This MGE is inserted at the attB site downstream
of orfX, a conserved gene among all staphylococci and
described recently as ribosomal methyltransferase of the
RlmH type (Boundy et al., 2013). Various reports suggest-
ing exchange of the SCCmec by horizontal transfer between
different species of Staphylococcaceae have been published
(Berglund & Söderquist, 2008; Bloemendaal et al., 2010).
According to the recent report of the International Working
Group on the Classification of Staphylococcal Cassette
Chromosome Elements (IWG-SCC) (www.sccmec.org), 11
types (I–XI) of SCCmec have been assigned for S. aureus,
which are defined by a combination of mec gene complex
class and cassette chromosome recombinase gene (ccr) allo-
type. Probably, these SCCmec elements preceded MRSA
and methicillin resistance as vectors for other genes in
staphylococci. There are similar MGEs harbouring capsule
group 1 factors of S. aureus, the fusidic acid resistance gene
fusB/Q6GD50, several heavy metal resistance operons,
enterotoxin H and the arginine catabolic mobile element,
all of which can be found in different Staphylococcaceae
members. This MGE is considered to confer better survival
ability and increased virulence to the strain (Monecke et al.,
2012; Hiramatsu et al., 2013).
In this study, we intended to assess the possible exchange of
SCCmec elements among isolates of different methicillin-
resistant (MR) Staphylococcus spp., which were recovered
from patients periodically admitted at the same dialysis
ward over several years. We proceeded by typing SCCmec
elements and sequencing the mecA from different MRS
isolates and subsequently by checking for new or recently
described mutations.
METHODS
Staphylococcus spp., isolates and identification. MRS were iso-
lated by nasal swabbing from patients admitted to the Frantz-Fanon
dialysis centre of Bejaia city (Algeria), during the first 6 months of 2012.
They were admitted periodically, once to three times a week, to undergo
dialysis sessions lasting 4 h. Swabs were cultured on mannitol salt agar
plates for 24 h at 37

C. A total of 105 patients have all been screened at
the beginning of the study and then once a month only if the last culture
was negative for MRS. Strains were identified by Gram staining, catalase
test, coagulase test in rabbit plasma (Remel), agglutination test and
API20Staph Gallery (bioMerieux). Then, identification was completed
by a PCR-restriction fragment length polymorphism using the ‘gap’
gene as previously recommended by Yugueros et al. (2001) and
Karakulska et al. (2012).
Antimicrobial drugs tested. The agar dilution method described in
the Clinical Laboratory Standards Institute guidelines was used. For
CNS, oxacillin resistance is considered for MICs greater than or equal to
0.5 µg ml 1. For S. aureus and Staphylococcus lugdunensis, MICs should
be greater than or equal to 4 µg ml 1. The antimicrobial drugs (Oxoid)
included oxacillin (1 µg), cefoxitin (30 µg), ciprofloxacin (5 µg), clinda-
mycin (2 µg), erythromycin (15 µg), gentamicin (10 µg), linezolid
(30 µg), rifampicin (5 µg), tetracycline (30 µg), teicoplanin (30 µg),
tobramycin (10 µg), trimethoprim–sulfamethoxazole (1.25/23.75 µg)
and vancomycin (30 µg). S. aureus and MRSA ATCC 29213 and 43300,
respectively, were used as quality control strains (CLSI, 2011).
SCCmec typing. All MRS isolates were subcultured on mannitol salt
agar, and DNA was extracted from few colonies, using lysostaphin, pro-
teinase K and RNase (Promega). For all PCRs, 1 µl of lysate was used.
Methicillin resistance was confirmed by PCR amplification of mecA
DNA (Milheiriço et al., 2007a). Then, each isolate was submitted to
SCCmec typing and SCCmec type IV subtyping methods. The first multi-
plex PCR (M-PCR) was performed to identify the SCCmec types I to VI
(Milheiriço et al., 2007a). The PCR products were then visualized on 3%
Tris/borate/EDTA-agarose gel. If not typeable by the first one, we used a
second method based on a system of six M-PCRs to identify the ccr gene
complex (ccr), the mec gene complex (mec) and specific structures in the
junkyard (J) regions (Kondo et al., 2007). The results were interpreted
according to the guidelines of the IWG-SCC (www.sccmec.org). A fur-
ther M-PCR was performed, as previously described by Milheiriço et al.
(2007b), to distinguish between the different SCCmec IV subtypes. Iden-
tity of SCCmec VII was already confirmed in another study (Djoudi
et al., 2014). MLST was performed on MRSA strains (Enright et al.,
2000). Statistical analysis was performed to assess the association of the
SCCmec types with different species isolated, using the chi-squared test
or Wilks G2 test, when necessary. P<0.05 was considered significant.
mecA DNA amplification and sequencing. The mecA gene was
amplified and sequenced in representative isolates, three S. aureus, two
S. haemolyticus, two S. sciuri and one each of Staphylococcus saprophyti-
cus, Staphylococcus lentus and Staphylococcus xylosus. DNA amplification
was carried out as recommended using a previously published set of
four pairs of primers (Eurofins), leading to four overlapping fragments
(Malik et al., 2006). mecA DNA fragments were purified with the CEN-
TRI-SEP columns (Applied Biosystems) and sequenced using the ABI
Prism Big-Dye Terminator v1.1 (Applied Biosystems). The conditions
of amplification and sequencing were those previously described by
Malik et al. (2006).
Sequence alignment. After partial sequencing, mecA genes were
reconstructed, using the overlapping regions, by the BioEdit software.
Sequence alignments were performed using CLUSTALW, as implemented
in MEGA 6 (www.megasoftware.net), using as reference the mecA
sequence of N315 (SA0038). Then, the aligned sequences and their
respective coded proteins were analysed to check for any mutations.
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RESULTS
MRS isolates and antimicrobial susceptibility
A total of 35 non-repetitive MRS isolates were recovered
from 105 patients, including 20 isolates of S. haemolyticus,
7 S. aureus, 4 S. sciuri and 2 S. saprophyticus, and 1 isolate of
S. xylosus and S. lentus, respectively (Table 1). Thirteen iso-
lates were from patients under antibiotic treatment.
Resistance to tetracycline (14/35, 40%), erythromycin (9/
35, 25.7%) and tobramycin (7/35, 20%) was the most
prevalent. Ten isolates (28.6%) were susceptible to all anti-
biotics tested other than b-lactams. Epidemiological data
and susceptibility testing results are shown in Table 1.
SCCmec typing
Only 16 (46%) of the 35 strains could be assigned to known
SCCmec types (Table 1). The first typing method character-
ized only nine strains, six with SCCmec IV in MRSA (four
isolates) and S. saprophyticus (two isolates) and three
SCCmec III in S. sciuri. The second method characterized a
ccr complex type 5 (C1) and mec complex type (C1) in
seven other strains, attributed to MRSA (three isolates) and
MR S. haemolyticus (four isolates). According to the guide-
lines of the IWG-SCC (www.sccmec.org), the respective
strains belong to the SCCmec VII. This result was confirmed
by sequencing the SCCmec of MRSA isolate no. 15 in our
last study (Djoudi et al., 2014) and comparison with a
sequence deposited in the GenBank database (http://www.
ncbi.nlm.nih.gov/nuccore/AB462393.1) (Takano et al.,
2008) exhibiting 100% nucleotide identity. Statistical analy-
sis confirmed the association of type VII to MR S. haemoly-
ticus and type IV to MRSA (P=0.027).
Nineteen isolates (54%) were not typeable by both methods,
presenting unusual profiles. For instance, in S. haemolyticus
strain no. 5, we only identified the ccr complex type 1 (A1B1),
and in S. sciuri strain no. 22, only mec complex B was ampli-
fied. More surprisingly, S. lentus strain no. 8 proved to carry a
ccr complex type C and a mec complex type B. These strains
carried also the mecA gene. Moreover, in six isolates of S. hae-
molyticus, only mecA was amplified, and no further known
component of SCCmec element was amplifiable.
mecA sequencing and alignment
Within the 10 mecA genes sequenced in MRS isolates, align-
ment by CLUSTALW (MEGA 6) showed a high homology with
mecA gene of S. aureus reference strain N315. Nevertheless,
nine mutations were revealed, including seven mutations
reported for the first time, to the best of our knowledge
(Table 2).
The S. sciuri strain no. 22 and S. xylosus strain no. 13 carried
a mecA with 100% homology to S. aureus N315 reference
strain. However, their SCCmec elements have not been
characterized. S. haemolyticus strain no. 4, carrying only
mecA with no further component of the SCCmec element,
shared an identical mutation with S. sciuri strain no. 31
(I154 N), carrying SCCmec III. The isolates of MRSA no. 6
(SCCmec IVh) and S. lentus no. 8 (SCCmec unidentified)
shared a mecA gene, with three identical mutations: N71K,
Y223D and G246E. S. sciuri strain no. 31 with SCCmec III
displayed the highest number of mutations: I154N, F231I,
G246E and I278F. The most frequent mutation was G246E,
which was identified in two isolates of MRSA and one iso-
late each of S. sciuri, S. saprophyticus and S. lentus, respec-
tively (Table 2).
DISCUSSION
High nasal carriage rates of staphylococci in patients under
dialysis are well acknowledged around the world. MR S.
haemolyticus is the more frequently isolated species. Indeed,
according to De Mattos et al. (2003) and Barbier et al.
(2010), 23% and 12% of isolates belonged to this species,
respectively. Barros et al. (2011) have considered S. haemo-
lyticus as an important hospital pathogen, as well as a carrier
of methicillin resistance genes. Our results significantly dif-
fer to the findings by Al-Bakri et al. (2013), with 80% iso-
lates of MR S. epidermidis and only 2% of MR S.
haemolyticus. We also report species rarely isolated from
human nasal specimens, like MR S. lentus and S. sciuri,
already reported to be causative agents of endocarditis
(Hedin & Widerström, 1998) and peritonitis (Rivera et al.,
2014), respectively. MRS isolates proved to be generally sus-
ceptible to antibiotics other than b-lactams. They exhibited
significant resistance only toward tetracycline, erythromycin
and tobramycin, according to reports from elsewhere (De
Mattos et al., 2003; Barros et al., 2011; Al-Bakri et al., 2013).
SCCmec IV was predominant in our MRSA strains, a com-
mon observation within MR staphylococci isolates in most
studies (Ruppe et al., 2009; Garza-Gonzalez et al., 2010; Al-
Bakri et al., 2013; Djoudi et al., 2014). The two MR S. sapro-
phyticus isolates carried SCCmec IVa; however, Söderquist &
Berglund (2009) reported that, in this species, SCCmec III
was predominant. In our study, SCCmec III was identified in
three isolates of MR S. sciuri, according to literature
(Machado et al., 2007; Söderquist & Berglund, 2009).
SCCmec IVa was recently described as the most prevalent
type among MR S. epidermidis in clinical and nasal carriage
isolates (Garza-Gonzalez et al., 2010; Al-Bakri et al., 2013).
SCCmec type VII, withmec complex type C1 and ccr complex
type C1, was identified in four MR S. haemolyticus and three
MRSA isolates. A study from four countries including Algeria
showed that class C mec complexes were significantly associ-
ated to S. haemolyticus than to S. epidermidis (P=0.001)
because classes C1 and C2 were found in 16/19 S. haemolyti-
cus strains (Ruppe et al., 2009). Furthermore, MR S. haemo-
lyticus has been putatively identified as a reservoir of mec
complex C and ccrC for the assembly of SCCmec elements
(Bouchami et al., 2012). Characterization of the SCCmec
type VII in ST5-MRSA isolates can be considered as possible
evidence for horizontal transfer of this MGE from MR S.
haemolyticus to methicillin-susceptible S. aureus, maybe
SCCmec typing and mecA sequencing in MRS
http://jmm.microbiologyresearch.org 1269
Downloaded from www.microbiologyresearch.org by
IP:  147.163.71.245
On: Fri, 26 May 2017 15:44:25
Table 1. Epidemiological data, drug susceptibility pattern and SCCmec typing of 35 MRS isolates, recovered from nasal carriage of
patients under dialysis treatment in Algeria
Isolate
number
Species Patient
age/
gender
Weekly
dialysis
frequency
Department
attendance
since
Antibiotic
exposure
Resistance
profile
mecA* ccr
complex
mec
complex
SCCmec
1 S.
haemolyticus
58/F 3 4 years b-Lactams TET +* C1 C1 VII
2 S.
haemolyticus
35/M 2 9 years – TET, ERY + C1 C1 VII
3 S.
saprophyticus
79/F 2 3 years Macrolides TET +* 2 (A2B2) B IVa
4 S.
haemolyticus
64/F 2 4 months – / +* / / mecA
only
5 S.
haemolyticus
62/F 1 1 month – TOB + 1 (A1B1) / NT
6 S. aureus 32/F 1 3 years Macrolides TET, ERY,
TOB
+* 2 (A2B2) B IVh
7 S.
haemolyticus
46/F 2 5 years b-Lactams ERY, CLI + C1 C1 VII
8 S. lentus 28/F 2 4 years – ERY +* C1 B NT
9 S.
haemolyticus
68/M 1 9 months – TET, TOB + C1 / NT
10 S.
haemolyticus
64/F 3 5 years Tetracyclines / + / B NT
11 S.
haemolyticus
46/F 2 3 years – / + / / mecA
only
12 S.
haemolyticus
63/M 2 3 years b-Lactams ERY,
TOB, RIF
+ C1 C1 VII
13 S. xylosus 63/F 3 18 years b-Lactams / +* / / NT
14 S.
haemolyticus
32/M 3 4 years Macrolides TET + / / mecA
only
15 S. aureus 67/F 3 7 years – TET +* C1 C1 VII
16 S.
haemolyticus
86/M 1 2 years – / + / / NT
17 S.
haemolyticus
81/F 2 1 month b-Lactams / + / / mecA
only
18 S.
haemolyticus
37/F 1 1 month – TET + / / mecA
only
19 S.
haemolyticus
32/F 1 3 years Macrolides ERY, TOB + / / NT
20 S.
haemolyticus
61/F 2 7 months b-Lactams RIF + / / NT
21 S.
haemolyticus
74/M 1 11 months – / + / / NT
22 S. sciuri 50/F 1 6 months – RIF +* / B NT
23 S. aureus 67/F 3 7 years – TET + C1 C1 VII
24 S.
haemolyticus
79/M 1 4 months – / + / / NT
25 S.
haemolyticus
77/F 1 1 month – / + 1 (A1B1) / mecA
only
26 S.
haemolyticus
64/F 2 3 years – / + / / NT
27 S. aureus 67/F 3 7 years – TET + C1 C1 VII
28 S. aureus 32/F 1 3 years b-Lactams ERY, TET,
TOB
+ 2 (A2B2) B IVh
29 S. aureus 66/M 2 2 years – TET, CIP +* 2 (A2B2) B IVc
30 S. sciuri 33/F 2 1 year – RIF + 3 (A3B3) A III
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inside our dialysis ward, and this hypothesis is supported by
statistical analysis (P=0.027). The same exchange has already
been observed, with horizontal transfer of SCCmec from MR
S. haemolyticus to methicillin-susceptible S. aureus strains,
resulting in a new MRSA clone with an epidemic potential
(Berglund & Söderquist, 2008). These findings, in accordance
with other studies, confirm that S. haemolyticus can be con-
sidered as a reservoir of ccrC and a source for generating
SCCmec VII (Ruppe et al., 2009; Urushibara et al., 2011;
Bouchami et al., 2012). In a similar way, MR S. epidermidis
appears to be a reservoir of ccrB and SCCmec IV (Ruppe
et al., 2009; Barbier et al., 2010; Bloemendaal et al., 2010).
With these observations, we suggest that the type of SCCmec
is defined by species where it was generated. Accordingly, it
could be stated that SCCmec VII comes fromMR S. haemoly-
ticus and SCCmec IV comes from MR S. epidermidis.
We also detected an unusual combination of ccrC complex
with mecB complex in an MR S. lentus isolate. This is a rare
finding but previously reported in two isolates of MR S. epi-
dermidis and Staphylococcus hominis (Ruppe et al., 2009).
However, 19 of 35 isolates were untypeable, a common
observation within MRS, underlying the high degree of vari-
ability in genetic background of this genus and the great
capacity of generating new SCCmec types (Ruppe et al., 2009;
Garza-Gonzalez et al., 2010; Urushibara et al., 2011; Al-Bakri
et al., 2013). Such findings underline the importance of
studying prevalence and composition of SCCmec in MRS, in
order to understand and predict the evolution of methicillin
Table 1. cont.
Isolate
number
Species Patient
age/
gender
Weekly
dialysis
frequency
Department
attendance
since
Antibiotic
exposure
Resistance
profile
mecA* ccr
complex
mec
complex
SCCmec
31 S. sciuri 63/F 3 3 years – CLI +* 3 (A3B3) A III
32 S. sciuri 33/F 3 4 years – TOB + 3 (A3B3) A III
33 S. aureus 34/M 1 4 years – TET, ERY + 2 (A2B2) B IVc
34 S.
saprophyticus
79/F 2 3 years b-Lactams TET + 2 (A2B2) B IVa
35 S.
haemolyticus
71/F 2 3 months – ERY + / / NT
F, female; M, male; NT, not typeable, mecA positive with unknown structures; CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; RIF,
rifampicin; TET, tetracycline; TOB, tobramycin.
*mecA sequenced.
Table 2. Missense mutations in mecA DNA from 10 MRS isolates, recovered from nasal carriage of patients under dialysis
treatment in Algeria
Isolate
number
Identification ST ccr
complex
mec
complex
SCCmec Mutations in
mecA DNA
Mutation in PBP2a protein/domain
of mutation (Kelley et al., 2015)
1 S.
haemolyticus
ND C1 C1 VII 675T>A S225R/nPBD
3 S.
saprophyticus
ND 2 (A2B2) B IVa 737G>A G246E/nPBD
4 S.
haemolyticus
ND / / mecA
only
461T>A, 1830T>A I154N/nPBD
6 S. aureus 80 2 (A2B2) B IVh 737G>A, 1645T>A G246E/nPBD, L549I/TD
8 S. lentus ND C1 B NT 213T>A, 423C>T, 667T>G,
737G>A
N71K/nPBD, Y223D/nPBD, G246E/nPBD
13 S. xylosus ND / / NT None None
15 S. aureus 5 C1 C1 VII 675T>A, 1768T>C S225R/nPBD, S590P/TD
22 S. sciuri ND / B NT None None
29 S. aureus 80 2 (A2B2) B IVc 213T>A, 423C>T, 667T>G,
737G>A
N71K/nPBD, Y223D/nPBD, G246E/nPBD
31 S. sciuri ND 3 (A3B3) A III 461T>A, 691T>A, 737G>A,
832A>T
I154N/nPBD, F231I/nPBD, G246E/nPBD,
I278F/nPBD
ND, Not done; nPBD, non-penicillin-binding domain; NT, not typeable, mecA positive with unknown structures; ST, sequence type; TD, transpepti-
dase domain.
SCCmec typing and mecA sequencing in MRS
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resistance in S. aureus. These 19 untypeable isolates include
six MR S. haemolyticus with onlymecA DNA amplified, with-
out any known fragment of staphylococcal chromosomal
cassette elements. Non-mecA-containing staphylococcal cas-
sette chromosomes were described in other studies
(Mongkolrattanothai et al., 2004; Hanssen & Sollid, 2006).
However, to our knowledge, no reports on only-mecA-con-
taining isolates were reported. However, whole-genome
sequencing is needed to confirm or deny this result.
Alignment and comparison of mecA DNA sequences to the
reference strain revealed infrequent mutations, confirming
the high stability of this gene in different species of Staphy-
lococcus Malik et al. (2006) reported that mecA genes from
animal isolates were identical to those found in human
MRS strains, presenting 100% homology. A further study
identified 32 mecA allelic variants sharing 95% nucleotide
similarity (Monecke et al., 2012). In sight of these findings,
consistently, two hypotheses can be considered. The first
one is that evolution of mecA inside the SCCmec element,
due to antibiotic exposure, can explain these mutations.
The second one, even if never reported, we suggest that a
mecA allele can be integrated, independently in any type of
SCCmec element and an SCCmec element can carry any one
of different mecA alleles, without any specificity.
A total of nine missense mutations were confirmed; two
had been previously described. The first one is G246E,
reported in Greece (Mendes et al., 2012), Thailand (Alm
et al., 2014) and Switzerland (Kelley et al., 2015). A limited
number of mutations on mecA DNA can be of utmost
importance; recently, Schaumburg et al. (2016) reported
that the high rates of resistance to the new cephalosporins,
ceftaroline and ceftobiprole, in isolates belonging to ST241,
were associated with a combination of three missense muta-
tions of PBP2a (N146K–N204K–G246E) in Africa. In this
study, we confirm the presence of this G246E missense
mutation in the European clone ST80-MRSA-IV and also
in MR S. haemolyticus, S. lentus and S. sciuri. The second
previously described mutation is S225R, which seems to be
present in West and Central Africa, but with no effect on
ceftobiprole and ceftaroline resistance (Schaumburg et al.,
2016). We confirm here that this mutation is also present in
ST5-MRSA-VII and MR S. haemolyticus.
In addition to these known mutations, we report, to the
best of our knowledge, new missense mutations in many
species of MRS that have not been already described. It
would be interesting to study the effect of such changes in
the PBP2a on resistance to fifth-generation cephalosporins,
especially because some of them are located in the
non-penicillin-binding protein domain. Mutations in this
part of PBP2a have already been reported as causing alloste-
ric changes, conferring resistance to ceftaroline through an
alteration of the salt bridge network at the allosteric site,
thereby deteriorating the access of a second ceftaroline mol-
ecule to the active site (Fishovitz et al., 2014).
Our results, together with previous reports, emphasize the
high degree of genetic diversity in mec gene complex and ccr
genes in MRS. Observing the inability to characterize the
different SCCmec types by the two methods used, an alter-
native strategy to identify increasing new types of
SCCmec, e.g. by next-generation sequencing, will likely
be needed in the near future. More widespread analysis and
data accumulation would help to understand the mecha-
nisms of horizontal transfer of SCCmec among staphylo-
cocci and to discover from which species different elements
originate. However, even if our results describe new muta-
tions in mecA gene and show that its allotypes seem unre-
lated to the type of SCCmec element, different missense
mutations herein described might certainly contribute to
understanding of the evolution of methicillin and new b-
lactam resistance by studying the correlation between these
mutations and the resistance levels.
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